-
-
-
-
-
-
-
89bio Announces Appointment of Kathy LaPorte to its Board of Directors
-
-
-
-
-
-
-
Precipio CEO Issues Shareholder Update Letter
-
-
-
-
-
-
-
Precipio Reminds Shareholders to Vote Before the Annual General Meeting on June 15, 2018
-
-
-
-
-
-
-
Precipio Launches Unique Lung Cancer Monitoring Test for Therapy Resistance
-
-
-
-
-
-
-
Precipio Commences Validation Study of Proprietary IV-Cell Cytogenetics Media at University of Pennsylvania
-
-
-
-
-
-
-
Precipio's ICE-COLD PCR(TM) Technology Selected by Methodist Healthcare System as Their Liquid Biopsy Platform
-
-
-
-
-
-
-
Precipio, Inc. Announces Closing of Public Offering
-
1,155,055 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

